Company record · ACBM · Services-Amusement & Recreation Services
Acro Biomedical Co., Ltd.
Acro Biomedical Co., Ltd.'s chief financial officer on the record is Jing-Zhou Chen, effective September 2, 2026, per the filing record.
The record holds 1 verified CFO change for Acro Biomedical Co., Ltd. from Form 8-K filings, filed September 2, 2026 and the CFO signature on its 10-K filed February 11, 2026.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Filled |
|---|---|
| Officer | Jing-Zhou Chen |
| Title as printed | chief executive officer and chief financial officer |
| Basis | Latest move: appointment, 8-K filed September 2, 2026 |
Seat timeline
2Every verified record for this seat, newest first, dated as the filing states it.
2026-09-02Appointment
Acro Biomedical Co., Ltd. appoints Jing-Zhou Chen as CFOeffective September 2, 2026 · 8-K filed September 2, 2026 · sec.gov, Item 5.02
2026-02-1110-K signature
Yu-Ting, Su signed the annual report as Director, chief executive officer and chief financial officer (principal executive, financial and accounting officer)
10-K filed February 11, 2026 · sec.gov
“/s/ Yu-Ting, Su Director, chief executive officer and February 11, 2026 Yu-Ting, Su chief financial officer (principal executive, financial and accounting officer)”
Company
| Ticker | ACBM |
|---|---|
| SEC CIK | 0001622996 |
| Industry (SIC) | Services-Amusement & Recreation Services (7900) |
| Roster note | No DEF 14A in the recent filings to cross-check. An 8-K with Item 5.02 was filed on 2026-09-02, after this 10-K; any CFO change it reports is tracked on the moves record. |
Same industry on the record
3Other companies the roster files under SIC “Services-Amusement & Recreation Services”.
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.